Related Articles With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma Stephen Taub How Hiddenite, a Young Long‑Short Fund, Delivered a Second Straight Triple‑Digit Year Stephen Taub AI and Process Integration Offer Managers a Path to Better Performance and Cost Control Sponsored by SS&C Advent